Boehringer Ingelheim, a Ridgefield biopharmaceutical company, announced the formation of the Metabolic Matters Steering Committee, a group of clinicians, advocates and experts working to close gaps in diagnosis and care for obesity and related metabolic conditions.

Boehringer Ingelheim estimates that 75% of people with obesity worldwide also have metabolic dysfunction-associated liver disease, and 34% have its more severe form, metabolic dysfunction-associated steatohepatitis. The company said care for these conditions is often fragmented across specialties.

Leslie Golden, MD, MPH, a practicing physician, chair of the Obesity Medicine Association and a committee member, said: “For many of us, the meeting of the Metabolic Matters Steering Committee earlier this year was our first time in a room with such a diverse group of leaders. We came from different backgrounds in advocacy and medicine, each representing different patient and professional communities, yet we were all connected by the common thread of metabolic health. Bringing our varied perspectives together is essential to address longstanding barriers and improve patient outcomes.”

At its inaugural meeting in 2026, the committee identified barriers that affect how people are diagnosed, treated and supported. These include limited public understanding of metabolic health, a gap between clinical guidance and real-world practice, and friction across the healthcare system that complicates coordinated management and referrals.

The committee set three priorities: increasing understanding of metabolic health, simplifying clinical decision-making and supporting more integrated care experiences.

“Obesity is closely connected to cardio-metabolic conditions, and our approach to caring for people living with these conditions should be equally connected,” said Brian Hilberdink, president of U.S. Human Pharma at Boehringer Ingelheim, “Through the Metabolic Matters Steering Committee, we are bringing together experts from across advocacy, medicine and research to help identify opportunities for more connected, coordinated and patient-centered approaches to metabolic health.”

Members represent the American Liver Foundation, American College of Physicians, American College of Gastroenterology, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, Obesity Action Coalition and The Obesity Society, along with leadership from the American Diabetes Association.